Stulak John M, Mehta Vivek, Schirger John A, Aaronson Keith D, Joyce Lyle D, Daly Richard C, Pagani Francis D, Maltais Simon
Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota.
Department of Cardiac Surgery, University of Michigan Health System, Ann Arbor, Michigan.
Ann Thorac Surg. 2015 Jun;99(6):1969-72; discussion 1972-4. doi: 10.1016/j.athoracsur.2015.01.036. Epub 2015 Apr 10.
The risk of device-related adverse events leading to death is abundant and ever-present after left ventricular assist device (VAD) implantation. Very few data specifically examine the causes of death related to length of time after VAD implantation.
Between October 2004 and February 2013, 493 patients (395 male, 80%) underwent primary continuous-flow VAD implantation at our institutions. The median age at implantation was 60 years (range, 18-79 years), and 301 patients (62%) underwent bridge to transplantation.
Follow-up was available for all patients (median, 13 months) for a total of 717 patient-years of support. There were 132 deaths during follow-up (median, 8 months; early, 5.5 years) after VAD implantation. The patients were grouped according to temporal occurrence of deaths: (1) early (30-day or index hospitalization) in 34 of 132 patients (26%), (2) between hospital dismissal and 6 months in 29 of 132 patients (22%), (3) 6 months to 1 year in 14 of 132 patients (11%), and (4) after 1 year in 55 of 132 patients (42%). The causes of death (%) at each time period are presented; the most common early cause was right ventricular failure/multisystem organ failure in 18 of 34 patients (61%); from dismissal to 6 months, and 6 months to 1 year, cerebral hemorrhage in 6 of 29 patients (21%) and 4 of 14 patients (29%), respectively; after 1 year, cerebral hemorrhage in 12 of 55 patients (22%) and right ventricular failure/multisystem organ failure in 11 of 55 patients (20%).
The causes of death vary according to time after VAD implantation. Understanding the temporal relationship of causes of mortality after VAD implantation is critical to the identification of varying specific risks in an effort to avoid morbidity, which may ultimately detract from a durable VAD outcome.
左心室辅助装置(VAD)植入后,与装置相关的导致死亡的不良事件风险很高且一直存在。很少有数据专门研究与VAD植入后时间长短相关的死亡原因。
2004年10月至2013年2月期间,493例患者(395例男性,占80%)在我们机构接受了初次连续流VAD植入。植入时的中位年龄为60岁(范围18 - 79岁),301例患者(62%)接受了过渡到移植治疗。
所有患者均有随访(中位随访时间13个月),总共提供了717患者 - 年的支持。VAD植入后随访期间有132例死亡(中位时间8个月;早期为5.5年)。根据死亡时间将患者分组:(1)早期(30天或索引住院期间),132例患者中有34例(26%);(2)出院至6个月期间,132例患者中有29例(22%);(3)6个月至1年,132例患者中有14例(11%);(4)1年后,132例患者中有55例(42%)。列出了每个时间段的死亡原因(%);最常见的早期原因是34例患者中有18例(61%)发生右心室衰竭/多系统器官衰竭;出院至6个月以及6个月至1年期间,29例患者中有6例(21%)和14例患者中有4例(29%)分别发生脑出血;1年后,55例患者中有12例(22%)发生脑出血,55例患者中有11例(20%)发生右心室衰竭/多系统器官衰竭。
VAD植入后的死亡原因随时间而变化。了解VAD植入后死亡原因的时间关系对于识别不同的特定风险以避免可能最终影响VAD长期效果的发病率至关重要。